
AZD 4017
CAS No. 1024033-43-9
AZD 4017 ( AZD4017 )
产品货号. M10111 CAS No. 1024033-43-9
AZD4017 是一种有效、选择性、可口服生物利用的人 11β-HSD1,IC50 为 7 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1320 | 有现货 |
![]() ![]() |
10MG | ¥2341 | 有现货 |
![]() ![]() |
25MG | ¥4682 | 有现货 |
![]() ![]() |
50MG | ¥6747 | 有现货 |
![]() ![]() |
100MG | ¥9315 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称AZD 4017
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述AZD4017 是一种有效、选择性、可口服生物利用的人 11β-HSD1,IC50 为 7 nM。
-
产品描述AZD4017 is a potent, selective, and orally bioavailable human 11β-HSD1 with IC50 of 7 nM, shows no significant activity against 11β-HSD1 and 17β-HSD1, 17β-HSD3 (IC50>30 uM); AZD4017 is inactive (<25% inhibition at 10 μM) against Cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4), and lower potency against the mouse, rat and dog 11β-HSD1 (IC50=750-4000 nM); demonstrates the dose dependent inhibition of 11β-HSD1 in vivo.Cushing Disease Phase 2 Clinical.
-
体外实验AZD 4017 displays excellent selectivity versus the related enzymes 11-βHSD2, 17β-HSD1, 17β-HSD3 (all IC50>30 μM) and shows no measurable activity against the glucocorticoid and mineralocorticoid receptors. Despite having high potency for the human form of 11β-HSD1, AZD 4017 shows much reduced activity across species with the exception of cynomolgous monkey (IC50=0.029 μM). Additionally, as it is believed that adipose is a key target organ, inhibition of 11β-HSD1 activity is measured in isolated human adipocytes from nondiabetic volunteers. AZD 4017 is shown to be a potent inhibitor in this key target tissue (IC50=0.002 μM) in good agreement with the enzyme potency, thus providing some confidence that AZD 4017 is not restricted from adipose tissue by the fact that it was acidic.
-
体内实验Since AZD 4017 has lower potency against the mouse enzyme, only a limited number of preclinical pharmacodynamic measurements are performed. Increasing the dose further led to a maximal effect of approximately 70% inhibition at 1500 mg/kg, equivalent to 10×IC50 in the mouse, demonstrating the dose dependent inhibition of 11β-HSD1 by AZD 4017 in this model.
-
同义词AZD4017
-
通路Metabolic Enzyme/Protease
-
靶点11β-HSD
-
受体11β-HSD
-
研究领域Endocrinology
-
适应症Cushing Disease
化学信息
-
CAS Number1024033-43-9
-
分子量419.58
-
分子式C22H33N3O3S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 125 mg/mL (297.92 mM)
-
SMILESO=C(O)C[C@H]1CN(C2=NC(SCCC)=C(C(NC3CCCCC3)=O)C=C2)CCC1
-
化学全称2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Scott JS, et al. J Med Chem. 2012 Jun 28;55(12):5951-64.